Bayer was founded in 1863 as a dye maker in Wuppertal, the hometown of Karl Marx’s collaborator Friedrich Engels. It later moved into medicines, commercialising aspirin around the turn of the ...

German drugmaker Bayer on Friday won an endorsement by the European Medicines Agency to extend the intervals between shots of ...

Changing the prescribing protocol for low-dose aspirin (LDA) for preeclampsia prevention from risk-based to universal ...

Bayer A.G.'s stock is undervalued but faces risks with declining profits & regulatory pressures. Click for my updated look at ...

Bayer Q1 profit declined to $1.45 billion, but earnings and sales topped estimates as pharma growth offset crop science ...

Bayer Pharmaceuticals' chief operating officer said the head of the top U.S. drug regulator recently reassured industry ...

An EMA committee has issued a positive opinion for a label extension that would allow six-month injection intervals for Eylea ...

to treat adult patients with cardiomyopathy (damage to the heart muscle) caused by variant or wild-type transthyretin amyloidosis (ATTR-CM). The new marketing authorisation was granted on 24th April, ...

Among 35 adults using technosphere insulin in the INHALE-3 trial, 74% increased their daily dose by more than 4 U at 30 weeks. Total daily inhaled insulin dose increased from 36 U at 4 days to 52 ...

“Our findings suggest that either dose may be a reasonable choice when using aspirin to prevent preeclampsia,” Lina Bergman, PhD, and colleagues wrote. The nationwide cohort study included 13,828 ...